GlassScriptPhysician profile
Joseph Theodore Brown
NPI 1154469179
$2,646.76
in general payments reported to CMS, 2019-2025
23 companies · $252 in 2025
The $252 reported for 2025 was more than what 84% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $27.48 · 2021: $91.50 · 2022: $156 · 2023: $509 · 2024: $1,489 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184 · Travel and Lodging: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.10 |
| Travel and Lodging | $1,066.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $1,106.17 | 2023-2024 | |
| Atricure, INC. | $606.51 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Astrazeneca Pharmaceuticals LP | $116.92 | 2023 | Andexxa |
| Edwards Lifesciences Corporation | $109.41 | 2022-2024 | Hemosphere |
| Abbott Laboratories | $94.55 | 2023 | 2nd Gen Centrimag Primary Console |
| Medtronic, INC. | $93.34 | 2024-2025 | Bis, Mcgrath Mac, Invos |
| Abiomed | $76.01 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $75.56 | 2019-2024 | Bridion |
| Allergan, INC. | $54.74 | 2019-2021 | |
| Davol INC. | $44.00 | 2025 | Arista |
| Kci USA, INC. | $37.77 | 2021-2023 | Prevena |
| Becton, Dickinson and Company | $35.28 | 2025 | Hemosphere |
| Lemaitre Vascular, INC. | $34.39 | 2022-2025 | Restoreflow |
| Horizon Therapeutics Plc | $21.15 | 2021 | |
| Masimo Corporation | $20.71 | 2025 | Sedline |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $18.33 | 2024 | |
| Getinge USA Sales, LLC | $16.62 | 2019 | |
| Fisher & Paykel Healthcare INC | $16.23 | 2025 | Fisher & Paykel Healthcare |
| Nuwellis, INC. | $15.89 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $15.70 | 2020 | |
| Mallinckrodt Enterprises LLC | $15.10 | 2019 | |
| Mallinckrodt Hospital Products INC. | $11.78 | 2020 | |
| Molnlycke Health Care US, LLC | $10.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.